These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30125244)

  • 1. Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
    Scarr E; Hopper S; Vos V; Seo MS; Everall IP; Aumann TD; Chana G; Dean B
    J Psychiatry Neurosci; 2018 Aug; 43(5):338-346. PubMed ID: 30125244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
    Scarr E; Hopper S; Vos V; Seo MS; Everall IP; Aumann TD; Chana G; Dean B
    J Psychiatry Neurosci; 2018 May; 43(4):170202. PubMed ID: 29848411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.
    Hopper S; Pavey GM; Gogos A; Dean B
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):640-650. PubMed ID: 31428788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of muscarinic M1 receptors in the human hippocampus.
    Scarr E; Seo MS; Aumann TD; Chana G; Everall IP; Dean B
    J Chem Neuroanat; 2016 Nov; 77():187-192. PubMed ID: 27435807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA.
    Scarr E; Craig JM; Cairns MJ; Seo MS; Galati JC; Beveridge NJ; Gibbons A; Juzva S; Weinrich B; Parkinson-Bates M; Carroll AP; Saffery R; Dean B
    Transl Psychiatry; 2013 Feb; 3(2):e230. PubMed ID: 23423139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Dean B; Soulby A; Evin GM; Scarr E
    Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
    Scarr E; Cowie TF; Kanellakis S; Sundram S; Pantelis C; Dean B
    Mol Psychiatry; 2009 Nov; 14(11):1017-23. PubMed ID: 18317461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.
    Sabbir MG; Speth RC; Albensi BC
    J Alzheimers Dis; 2022; 90(2):727-747. PubMed ID: 36155524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?
    Squires RF; Lajtha A; Saederup E; Palkovits M
    Neurochem Res; 1993 Feb; 18(2):219-23. PubMed ID: 8097289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.
    Habl G; Schmitt A; Zink M; von Wilmsdorff M; Yeganeh-Doost P; Jatzko A; Schneider-Axmann T; Bauer M; Falkai P
    Neuropsychobiology; 2012; 66(1):57-62. PubMed ID: 22797278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower levels of cortical [
    Dean B; Haroutunian V; Scarr E
    Schizophr Res; 2023 May; 255():274-282. PubMed ID: 37079947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
    Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Sci; 2001 Dec; 193(1):23-8. PubMed ID: 11718746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.
    Dean B; Hopper S; Conn PJ; Scarr E
    Neuropsychopharmacology; 2016 May; 41(6):1620-8. PubMed ID: 26511338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.
    Seo MS; Scarr E; Dean B
    Schizophr Res; 2014 Sep; 158(1-3):247-54. PubMed ID: 25037527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of gamma-aminobutyric acid(B) receptor in the hippocampus of subjects with schizophrenia.
    Mizukami K; Sasaki M; Ishikawa M; Iwakiri M; Hidaka S; Shiraishi H; Iritani S
    Neurosci Lett; 2000 Apr; 283(2):101-4. PubMed ID: 10739885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.
    Blennow K; Bogdanovic N; Heilig M; Grenfeldt B; Karlsson I; Davidsson P
    J Neural Transm (Vienna); 2000; 107(8-9):1085-97. PubMed ID: 11041284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
    Sabbir MG
    J Alzheimers Dis; 2024; 98(1):247-264. PubMed ID: 38427478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal localization of m1 muscarinic receptor immunoreactivity in the rat basolateral amygdala.
    McDonald AJ; Mascagni F
    Brain Struct Funct; 2010 Jul; 215(1):37-48. PubMed ID: 20503057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinoceptive cells in rat cerebral cortex: somatodendritic immunoreactivity for muscarinic receptor and cytoskeletal proteins.
    Woolf NJ
    J Chem Neuroanat; 1993; 6(6):375-90. PubMed ID: 7511392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
    Broadbelt K; Jones LB
    J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.